Epidemiology and hereditary aspects of acute leukemia

Neoplastic Diseases of the Blood

Volumn , Issue , 2013, Pages 199-212

  Linet, Martha S ^a   Dores, Graça M ^b   Kim, Clara J ^a   Devesa, Susan S ^a   Morton, Lindsay M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chemical etiology; Familial acute leukemia; Leukemia genetics; Radiation etiology; Seasonal influence on acute leukemia

Indexed keywords

EID: 84929564352     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3764-2_15     Document Type: Chapter

References (169)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
2. Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008.
3. Shu X, Perentesis J, Wen W, et al. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukmia: A report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev. 2004;13:1230-5.
4. Spector LG, Xie Y, Robison LL, et al. Maternal diet and infant leukemia: The DNA topoisomerase II inhibitor hypothesis: A report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev. 2005;14:651-5.
5. Scelo G, Metayer C, Zhang L, et al. Household exposure to paint and petroleum solvents, chromosomal translocations, and the risk of childhood leukemia. Environ Health Perspect. 2009;117:133-9.
6. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program ( http://www.seer.cancer.gov ) SEER∗Stat Database: Incidence-SEER-9 Regs Research Data, Nov 2009 Sub (1973-2007) < Katrina/Rita Population Adjustment>, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission.
7. Linet MS, Devesa SS, Morgan GJ. The leukemias. In: Schottenfeld D, Fraumeni Jr J, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 841-71.
8. Ross J, Spector L. Cancers in children. In: Schottenfeld D, Fraumeni Jr J, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 1251-68.
9. Anderson LM, Diwan BA, Fear NT, Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect. 2000;108 Suppl 3:573-94.
10. Greaves MF. Biological models for leukaemia and lymphoma. IARC Sci Publ. 2004;351-72.
11. van Steensel-Moll HA, Valkenburg HA, Vandenbroucke JP, van Zanen GE. Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol. 1985;14:555-9.
12. Yeazel M, Buckley J, Woods W, Ruccione K, Robison L. History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. Cancer. 1995;75:1718-27.
13. Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol. 1999;28:631-9.
14. Roman E, Simpson J, Ansell P, et al. Perinatal and reproductive factors: A report on haematological malignancies from the UKCCS. Eur J Cancer. 2005;41:749-59.
15. Ross JA, Potter JD, Shu XO, Reaman GH, Lampkin B, Robison LL. Evaluating the relationships among maternal reproductive history, birth characteristics, and infant leukemia: A report from the Children's Cancer Group. Ann Epidemiol. 1997;7:172-9.
16. Stewart A, Webb J, Hewitt D. A survey of childhood malignancies. Br Med J. 1958;1:1495-508.
17. Westergaard T, Andersen P, Pedersen J, et al. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: A population-based cohort study. J Natl Cancer Inst. 1997;89:939-47.
18. Cnattingius S, Zack M, Ekbom A, Gunnarskog J, Linet M, Adami H. Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biomarkers Prev. 1995;4:441-5.
19. Cnattingius S, Zack M, Ekbom A, et al. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst. 1995;87:908-14.
20. Macmahon B, Newill VA. Birth characteristics of children dying of malignant neoplasms. J Natl Cancer Inst. 1962;28:231-44.
21. Shu XO, Gao YT, Brinton LA, et al. A population-based case-control study of childhood leukemia in Shanghai. Cancer. 1988;62:635-44.
22. Maule MM, Vizzini L, Czene K, Akre O, Richiardi L. How the effect of maternal age on the risk of childhood leukemia changed over time in Sweden, 1960-2004. Environ Health Perspect. 2009;117:299-302.
23. Smith M. Considerations on a possible viral etiology for B-precursor acute lymphoblastic leukemia of childhood. J Immunother. 1997;20:89-100.
24. Hakulinen T, Hovi L, Karkinen J, Penttinen K, Saxen L. Association between influenza during pregnancy and childhood leukaemia. Br Med J. 1973;4:265-7.
25. Lehtinen M, Koskela P, Ogmundsdottir H, et al. Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring. Am J Epidemiol. 2003;158:207-13.
26. Randolph VL, Heath Jr CW. Influenza during pregnancy in relation to subsequent childhood leukemia and lymphoma. Am J Epidemiol. 1974;100:399-409.
27. Tedeschi R, Luostarinen T, Marus A, et al. No risk of maternal EBV infection for childhood leukemia. Cancer Epidemiol Biomarkers Prev. 2009;18:2790-2.
28. Smith MA, Strickler HD, Granovsky M, et al. Investigation of leukemia cells from children with common acute lymphoblastic leukemia for genomic sequences of the primate polyomaviruses JC virus, BK virus, and simian virus 40. Med Pediatr Oncol. 1999;33:441-3.
29. MacKenzie J, Gallagher A, Clayton RA, et al. Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia. 2001;15:415-21.
30. Isa A, Priftakis P, Broliden K, Gustafsson B. Human parvovirus B19 DNA is not detected in Guthrie cards from children who have developed acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42:357-60.
31. Kaatsch P, Scheidemann-Wesp U, Schuz J. Maternal use of antibiotics and cancer in the offspring: results of a case-control study in Germany. Cancer Causes Control. 2010;21:1335-45.
32. Wen W, Shu X-O, Potter J, et al. Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer. 2002;95:1786-94.
33. Brinton LA, Kruger Kjaer S, Thomsen BL, et al. Childhood tumor risk after treatment with ovulation-stimulating drugs. Fertil Steril. 2004;81:1083-91.
34. Robison LL, Buckley JD, Daigle AE, et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer. 1989;63:1904-11.
35. Trivers K, Mertens A, Ross J, Steinbuch M, Olshan A, Robison L. Parental marijuana use and risk of childhood acute myeloid leukaemia: A report from the Children's Cancer Group (United States and Canada). Paediatr Perinat Epidemiol. 2006;20:110-8.
36. Shu X-O, Potter J, Linet M, et al. Diagnostic X-rays and ultrasound exposure and risk of childhood acute lymphoblastic leukemia by immunophenotype. Cancer Epidemiol Biomarkers Prev. 2002;11:177-85.
37. Wakeford R. Childhood leukaemia following medical diagnostic exposure to ionizing radiation in utero or after birth. Radiat Prot Dosimetry. 2008;132:166-74.
38. Preston DL, Cullings H, Suyama A, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst. 2008;100:428-36.
39. Hatch M, Brenner A, Bogdanova T, et al. A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout. J Clin Endocrinol Metab. 2009;94:899-906.
40. United Nations. Effects of ionizing radiation: United Nations Scientific Committee on the Effects of Atomic Radiation-UNSCEAR, 2006 Report, Volume 1-Report to the General Assembly, with Scientific Annexes A and B. Vienna: United Nations; 2008.
41. Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terrell JD. Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ. 1990;300:423-9.
42. Roman E, Doyle P, Maconochie N, Davies G, Smith PG, Beral V. Cancer in children of nuclear industry employees: report on children aged under 25 years from nuclear industry family study. BMJ. 1999;318:1443-50.
43. Roman E, Doyle P, Ansell P, Bull D, Beral V. Health of children born to medical radiographers. Occup Environ Med. 1996;53: 73-9.
44. Johnson KJ, Alexander BH, Doody MM, et al. Childhood cancer in the offspring born in 1921-1984 to US radiologic technologists. Br J Cancer. 2008;99:545-50.
45. Hug K, Grize L, Seidler A, Kaatsch P, Schuz J. Parental occupational exposure to extremely low frequency magneticfields and childhood cancer: A German case-control study. Am J Epidemiol. 2010;171:27-35.
46. Zahm SH, Ward MH. Pesticides and childhood cancer. Environ Health Perspect. 1998;106 Suppl 3:893-908.
47. Infante-Rivard C, Weichenthal S. Pesticides and childhood cancer: an update of Zahm and Ward's 1998 review. J Toxicol Environ Health B Crit Rev. 2007;10:81-99.
48. Wigle D, Turner M, Krewski D. A systematic review and metaanalysis of childhood leukemia and parental occupational pesticide exposure. Environ Health Perspect. 2009;117:1505-13.
49. Van Maele-Fabry G, Lantin AC, Hoet P, Lison D. Childhood leukaemia and parental occupational exposure to pesticides: A systematic review and meta-analysis. Cancer Causes Control. 2010;21:787-809.
50. Wigle DT, Arbuckle TE, Turner MC, et al. Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J Toxicol Environ Health B Crit Rev. 2008;11:373-517.
51. Institute of Medicine (U.S.) Committee on the Assessment of Asthma and Indoor Air. Clearing the Air: Asthma and Indoor Air Exposures. Washington: National Academy Press; 2000.
52. McKinney P, Fear N, Stockton D, UK Childhood Cancer Study Investigators. Parental occupation at periconception:findings from the United Kingdom Childhood Cancer Study. Occup Environ Med. 2003;60:901-9.
53. Boffetta P, Tredaniel J, Greco A. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis. Environ Health Perspect. 2000;108:73-82.
54. Chang JS. Parental smoking and childhood leukemia. Methods Mol Biol. 2009;472:103-37.
55. Lee K-M, Ward M, Han S, et al. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res. 2009;33:250-8.
56. Infante-Rivard C, El-Zein M. Parental alcohol consumption and childhood cancers: A review. J Toxicol Environ Health B Crit Rev. 2007;10:101-29.
57. MacArthur AC, McBride ML, Spinelli JJ, Tamaro S, Gallagher RP, Theriault G. Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: The Cross-Canada Childhood Leukemia Study. Cancer Causes Control. 2008;19:283-95.
58. Latino-Martel P, Chan DSM, Druesne-Pecollo N, Barrandon E, Hercberg S, Norat T. Maternal alcohol consumption during pregnancy and risk of childhood leukemia: systematic review and metaanalysis. Cancer Epidemiol Biomarkers Prev. 2010;19:1238-60.
59. Jensen C, Block G, Buffler P, et al. Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control. 2004;15:559-70.
60. Petridou E, Ntouvelis E, Dessypris N, Terzidis A, Trichopoulos D, Childhood Hematology-Oncology Group. Maternal diet and acute lymphoblastic leukemia in young children. Cancer Epidemiol Biomarkers Prev. 2005;14:1935-9.
61. Milne E, Royle J, Miller M, et al. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer. 2010;126:2690-9.
62. Kwan M, Metayer C, Crouse V, Buffler P. Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am J Epidemiol. 2007;165:27-35.
63. Caughey R, Michels K. Birth weight and childhood leukemia: A meta-analysis and review of the current evidence. Int J Cancer. 2009;124:2658-70.
64. Milne E, Royle J, de Klerk N, et al. Fetal growth and risk of childhood acute lymphoblastic leukemia: results from an Australian case-control study. Am J Epidemiol. 2009;170:221-8.
65. Shu X-O, Linet M, Steinbuch M, et al. Breast-feeding and risk of childhood acute leukemia. J Natl Cancer Inst. 1999;91:1765-72.
66. UK Childhood Cancer Study Investigators. Breastfeeding and childhood cancer. Br J Cancer. 2001;85:1685-94.
67. Martin R, Gunnell D, Owen C, Smith G. Breast-feeding and childhood cancer: A systematic review with metaanalysis. Int J Cancer. 2005;117:1020-31.
68. MacArthur AC, McBride ML, Spinelli JJ, Tamaro S, Gallagher RP, Theriault GP. Risk of childhood leukemia associated with vaccination, infection, and medication use in childhood: The Cross-Canada Childhood Leukemia Study. Am J Epidemiol. 2008;167:598-606.
69. Alexander FE. Clusters and clustering of childhood cancer: A review. Eur J Epidemiol. 1999;15:847-52.
70. Heath Jr CW. Community clusters of childhood leukemia and lymphoma: evidence of infection? Am J Epidemiol. 2005;162:817-22.
71. Rubin C, Holmes A, Belson M, et al. Investigating childhood leukemia in Churchill County, Nevada. Environ Health Perspect. 2007;115:151-7.
72. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6:193-203.
73. Urayama K, Buffler P, Gallagher E, Ayoob J, Ma X. A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol. 2010:1-15.
74. Gilham C, Peto J, Simpson J, et al. Day care in infancy and risk of childhood acute lymphoblastic leukaemia:findings from UK case-control study. BMJ. 2005;330:1294.
75. Neglia JP, Linet MS, Shu XO, et al. Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer. 2000;82:234-40.
76. Roman E, Simpson J, Ansell P, et al. Childhood acute lymphoblastic leukemia and infections in thefirst year of life: A report from the United Kingdom Childhood Cancer Study. Am J Epidemiol. 2007;165:496-504.
77. Kinlen L. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet. 1988;2:1323-7.
78. Kinlen LJ. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer. 1995;71:1-5.
79. Law G, Parslow R, Roman E, United Kingdom Childhood Cancer Study Investigators. Childhood cancer and population mixing. Am J Epidemiol. 2003;158:328-36.
80. McNally R, Eden T. An infectious aetiology for childhood acute leukaemia: A review of the evidence. Br J Haematol. 2004;127(3):243-63.
81. Linabery A, Jurek A, Duval S, Ross J. The association between atopy and childhood/adolescent leukemia: A meta-analysis. Am J Epidemiol. 2010;171:749-64.
82. Linet MS, Kim KP, Rajaraman P. Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatr Radiol. 2009;39 Suppl 1:S4-26.
83. Boice Jr J. Ionizing radiation. In: Schottenfeld D, Fraumeni Jr J, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 2006. p. 259-935.
84. Ron E, Modan B, Boice Jr JD. Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol. 1988;127:713-25.
85. Allard A, Haddy N, Le Deley MC, et al. Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999. Int J Radiat Oncol Biol Phys. 2010;78(5):1474-82.
86. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 1994;137:S68-97.
87. Darby SC, Doll R. Fallout, radiation doses near Dounreay, and childhood leukaemia. Br Med J (Clin Res Ed). 1987;294:603-7.
88. Lubin JH, Linet MS, Boice Jr JD, et al. Case-control study of childhood acute lymphoblastic leukemia and residential radon exposure. J Natl Cancer Inst. 1998;90:294-300.
89. Kaletsch U, Kaatsch P, Meinert R, Schuz J, Czarwinski R, Michaelis J. Childhood cancer and residential radon exposure-results of a population-based case-control study in Lower Saxony (Germany). Radiat Environ Biophys. 1999;38:211-5.
90. UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 1: radon gas. Br J Cancer. 2002;86:1721-6.
91. Steinbuch M, Weinberg CR, Buckley JD, Robison LL, Sandler DP. Indoor residential radon exposure and risk of childhood acute myeloid leukaemia. Br J Cancer. 1999;81:900-6.
92. Ahlbom A, Day N, Feychting M, et al. A pooled analysis of magneticfields and childhood leukaemia. Br J Cancer. 2000;83:692-8.
93. Boorman GA, Rafferty CN, Ward JM, Sills RC. Leukemia and lymphoma incidence in rodents exposed to low-frequency magneticfields. Radiat Res. 2000;153:627-36.
94. Ma X, Buffler PA, Gunier RB, et al. Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect. 2002;110:955-60.
95. Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology. 1999;10:481-7.
96. Buckley JD, Robison LL, Swotinsky R, et al. Occupational exposures of parents of children with acute nonlymphocytic leukemia: A report from the Childrens Cancer Study Group. Cancer Res. 1989;49:4030-7.
97. Freedman DM, Stewart P, Kleinerman RA, et al. Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health. 2001;91:564-7.
98. Kwan M, Block G, Selvin S, Month S, Buffler P. Food consumption by children and the risk of childhood acute leukemia. Am J Epidemiol. 2004;160:1098-107.
99. Liu C-Y, Hsu Y-H, Wu M-T, et al. Cured meat, vegetables, and bean-curd foods in relation to childhood acute leukemia risk: A population based case-control study. BMC Cancer. 2009;9:15.
100. Golding J, Greenwood R, Birmingham K, Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ. 1992;305:341-6.
101. Roman E, Fear N, Ansell P, et al. Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. Br J Cancer. 2002;86:63-9.
102. Martling U, Mattsson A, Travis LB, Holm LE, Hall P. Mortality after long-term exposure to radioactive Thorotrast: A forty-year follow-up survey in Sweden. Radiat Res. 1999;151:293-9.
103. Andersson M, Carstensen B, Visfeldt J. Leukemia and other related hematological disorders among Danish patients exposed to Thorotrast. Radiat Res. 1993;134:224-33.
104. Weiss HA, Darby SC, Fearn T, Doll R. Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiat Res. 1995;142:1-11.
105. Inskip PD, Kleinerman RA, Stovall M, et al. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiat Res. 1993;135:108-24.
106. Griem ML, Kleinerman RA, Boice Jr JD, Stovall M, Shefner D, Lubin JH. Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst. 1994;86:842-9.
107. Inskip P. Second cancers following radiotherapy. In: Neugut AL, Meadows AT, editors. Multiple primary cancers. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 91-135.
108. Leone G, Fianchi L, Pagano L, Voso MT. Incidence and susceptibility to therapy-related myeloid neoplasms. Chem Biol Interact. 2010;184:39-45.
109. Larson RA, Le Beau MM. Therapy-related myeloid leukaemia: A model for leukemogenesis in humans. Chem Biol Interact. 2005;153-154:187-95.
110. Czader M, Orazi A. Therapy-related myeloid neoplasms. Am J Clin Pathol. 2009;132:410-25.
111. Kaatsch P, Reinisch I, Spix C, et al. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany. Cancer Causes Control. 2009;20:965-80.
112. Kwong Y-L. Azathioprine: association with therapy-related myelodysplastic syndrome and acute myeloid leukemia. J Rheumatol. 2010;37:485-90.
113. Ohara A, Kojima S, Hamajima N, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997;90:1009-13.
114. Shivakumar R, Tan W, Wilding GE, Wang ES, Wetzler M. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia-A review of 101 cases. Ann Oncol. 2008;19:1634-8.
115. Richardson D, Sugiyama H, Nishi N, et al. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950-2000. Radiat Res. 2009;172:368-82.
116. Krestinina L, Preston DL, Davis FG, et al. Leukemia incidence among people exposed to chronic radiation from the contaminated Techa River, 1953-2005. Radiat Environ Biophys. 2010;49: 195-201.
117. International Agency for Research on Cancer. IARC Monographs. Non-ionizing radiation, part 1: Static and extremely low-frequency (ELF) electric and magneticfields. Lyon: IARC; 2002.
118. Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E. Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies. Radiology. 2004;233:313-21.
119. Linet MS, Freedman DM, Mohan AK, et al. Incidence of haematopoietic malignancies in US radiologic technologists. Occup Environ Med. 2005;62:861-7.
120. Cardis E, Gilbert ES, Carpenter L, et al. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res. 1995;142:117-32.
121. Muirhead CR, O'Hagan JA, Haylock RG, et al. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br J Cancer. 2009;100:206-12.
122. Romanenko AY, Finch SC, Hatch M, et al. The Ukrainian-American study of leukemia and related disorders among Chornobyl cleanup workers from Ukraine: III. Radiation risks. Radiat Res. 2008;170:711-20.
123. Shilnikova NS, Preston DL, Ron E, et al. Cancer mortality risk among workers at the Mayak nuclear complex. Radiat Res. 2003;159:787-98.
124. Schnatter AR, Rosamilia K, Wojcik NC. Review of the literature on benzene exposure and leukemia subtypes. Chem Biol Interact. 2005;153-154:9-21.
125. Khalade A, Jaakkola MS, Pukkala E, Jaakkola JJ. Exposure to benzene at work and the risk of leukemia: A systematic review and meta-analysis. Environ Health. 2010;9:31.
126. Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the doserelated incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997;89:1065-71.
127. Ross J. Epidemiology and hereditary aspects of acute leukemia. In: Wiernick P, Goldman J, Dutcher J, Kyle R, editors. Neoplastic diseases of the blood. Cambridge: Cambridge University Press; 2006. p. 164-75.
128. Richardson S, Zittoun R, Bastuji-Garin S, et al. Occupational risk factors for acute leukaemia: A case-control study. Int J Epidemiol. 1992;21:1063-73.
129. Sinner PJ, Cerhan JR, Folsom AR, Ross JA. Positive association of farm or rural residence with acute myeloid leukemia incidence in a cohort of older women. Cancer Epidemiol Biomarkers Prev. 2005;14:2446-8.
130. Brownson R, Novotny T, Perry M. Cigarette smoking and adult leukemia. A meta-analysis. Arch Intern Med. 1993;153:469-75.
131. Ma X, Park Y, Mayne S, et al. Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP Cohort. Am J Epidemiol. 2010;171:312-22.
132. Correa A, Mohan A, Jackson L, Perry H, Helzlsouer K. Use of hair dyes, hematopoietic neoplasms, and lymphomas: A literature review. I. Leukemias and myelodysplastic syndromes. Cancer Invest. 2000;18:408.
133. Rauscher G, Shore D, Sandler D. Hair dye use and risk of adult acute leukemia. Am J Epidemiol. 2004;160:19-25.
134. Larsson S, Wolk A. Overweight and obesity and incidence of leukemia: A meta-analysis of cohort studies. Int J Cancer. 2008;122:1418-21.
135. Li Y, Moysich K, Baer M, et al. Intakes of selected food groups and beverages and adult acute myeloid leukemia. Leuk Res. 2006;30:1507-15.
136. Zhang M, Zhao K, Zhang X, Holman C. Possible protective effect of green tea intake on risk of adult leukemia. Br J Cancer. 2008;98:168-70.
137. Kasim K, Levallois P, Abdous B, Auger P, Johnson K. Lifestyle factors and the risk of adult leukemia in Canada. Cancer Causes Control. 2005;16:489-500.
138. Gorini G, Stagnaro E, Fontana V, et al. Alcohol consumption and risk of leukemia: A multicenter case-control study. Leuk Res. 2007;31:379-86.
139. Klatsky A, Li Y, Baer D, Armstrong M, Udaltsova N, Friedman G. Alcohol consumption and risk of hematologic malignancies. Ann Epidemiol. 2009;19:746-53.
140. Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukaemia-A review. Br J Haematol. 2008;140:123-32.
141. Couto E, Chen B, Hemminki K. Association of childhood acute lymphoblastic leukaemia with cancers in family members. Br J Cancer. 2005;93:1307-9.
142. Rommens J, Durie P. Shwachman-Diamond syndrome. In: Pagon R, Bird T, Dolan C, Stephens K, editors. GeneReviews [Internet]. Seattle, WA: University of Washington; 2008.
143. Alter BP, Giri N, Savage SA, et al. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol. 2010;150:179-88.
144. Federman N, Sakamoto KM. The genetic basis of bone marrow failure syndromes in children. Mol Genet Metab. 2005;86:100-9.
145. Varley J, Evans D, Birch J. Li-Fraumeni syndrome-A molecular and clinical review. Br J Cancer. 1997;76:1-14.
146. German J. Bloom's syndrome. XX. Thefirst 100 cancers. Cancer Genet Cytogenet. 1997;93:100-6.
147. Olsen JH, Hahnemann JM, Borresen-Dale AL, et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst. 2001;93:121-7.
148. Gelb BD, Tartaglia M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum Mol Genet. 2006;15 Spec No 2:R220-6.
149. Yohay K. Neurofibromatosis type 1 and associated malignancies. Curr Neurol Neurosci Rep. 2009;9:247-53.
150. Bjørge T, Cnattingius S, Lie RT, Tretli S, Engeland A. Cancer risk in children with birth defects and in their families: A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev. 2008;17:500-6.
151. Xavier AC, Taub JW. Acute leukemia in children with Down syndrome. Haematologica. 2010;95:1043-5.
152. Bolufer P, Barragan E, Collado M, Cervera J, López J-A, Sanz MA. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res. 2006;30: 1471-91.
153. Vijayakrishnan J, Houlston R. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: A systematic review and meta-analysis. Haematologica. 2010;95:1405-14.
154. Trevino LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1001-5.
155. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1006-10.
156. Han S, Lee K-M, Park SK, et al. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res. 2010;34(10):1271-4.
157. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42:492-4.
158. Knight JA, Skol AD, Shinde A, et al. Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Blood. 2009;113:5575-82.
159. Mrózek K, Heinonen K, Bloomfield CD. Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol. 2001;14:19-47.
160. Manola KN. Cytogenetics of pediatric acute myeloid leukemia. Eur J Haematol. 2009;83:391-405.
161. Vrooman LM, Silverman LB. Childhood acute lymphoblastic leukemia: update on prognostic factors. Curr Opin Pediatr. 2009;21:1-8.
162. Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia. 2008;22:240-8.
163. Qian Z, Joslin JM, Tennant TR, et al. Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. Chem Biol Interact. 2010;184:50-7.
164. Taylor JA, Sandler DP, Bloomfield CD, et al. Ras oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst. 1992;84:1626-32.
165. Barletta E, Gorini G, Vineis P, et al. Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents. Carcinogenesis. 2004;25:749-55.
166. Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 2001;61:2542-6.
167. Wiemels JL, Xiao Z, Buffler PA, et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood. 2002;99:3801-5.
168. Lafiura KM, Bielawski DM, Posecion Jr NC, et al. Association between prenatal pesticide exposures and the generation of leukemia-associated T(8;21). Pediatr Blood Cancer. 2007;49:624-8.
169. Wiemels JL, Leonard BC, Wang Y, et al. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 2002;99:15101-6.